⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
RCKT News
Rocket Pharmaceuticals, Inc. Common Stock
Form 8-K
sec.gov
RCKT
RCKTW
Form 8-K
sec.gov
RCKTW
RCKT
Rocket Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results and Highlights Recent Progress
businesswire.com
RCKT
Rocket Pharmaceuticals to Participate in the 44th Annual J.P. Morgan Healthcare Conference
businesswire.com
RCKT
Beyond Traditional Drugs: Novel Platforms Targeting Hard-to-Treat Conditions
prnewswire.com
BEAM
CRSP
RCKT
SDGR
Rocket Pharmaceuticals to Participate in the 8 th Annual Evercore Healthcare Conference
businesswire.com
RCKT
Rocket Pharmaceuticals Reports Third Quarter 2025 Financial Results and Highlights Recent Progress
businesswire.com
RCKT
Rocket Pharmaceuticals Announces FDA Acceptance of BLA Resubmission of KRESLADI™ for the Treatment of Severe Leukocyte Adhesion Deficiency-I (LAD-I)
businesswire.com
RCKT
RCKT
Rocket Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
businesswire.com
RCKT
RCKT
Kuehn Law Encourages Investors of Rocket Pharmaceuticals, Inc. to Contact Law Firm
prnewswire.com
RCKT